Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients.

Na R, Grulich AE, Meagher NS, McCaughan GW, Keogh AM, Vajdic CM.

Am J Transplant. 2013 Jan;13(1):174-83. doi: 10.1111/j.1600-6143.2012.04302.x. Epub 2012 Oct 24.

2.

De novo cancer-related death in Australian liver and cardiothoracic transplant recipients.

Na R, Grulich AE, Meagher NS, McCaughan GW, Keogh AM, Vajdic CM.

Am J Transplant. 2013 May;13(5):1296-304. doi: 10.1111/ajt.12192. Epub 2013 Mar 6.

3.

Spectrum of cancer risk among US solid organ transplant recipients.

Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M.

JAMA. 2011 Nov 2;306(17):1891-901. doi: 10.1001/jama.2011.1592.

4.

Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.

Jensen AO, Svaerke C, Farkas D, Pedersen L, Kragballe K, Sørensen HT.

Acta Derm Venereol. 2010 Sep;90(5):474-9. doi: 10.2340/00015555-0919.

5.

Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation.

Hoffmann CJ, Subramanian AK, Cameron AM, Engels EA.

Transplantation. 2008 Sep 27;86(6):784-90. doi: 10.1097/TP.0b013e3181837761.

6.

The incidence of cancer in a population-based cohort of Canadian heart transplant recipients.

Jiang Y, Villeneuve PJ, Wielgosz A, Schaubel DE, Fenton SS, Mao Y.

Am J Transplant. 2010 Mar;10(3):637-45. doi: 10.1111/j.1600-6143.2009.02973.x. Epub 2010 Feb 1.

7.

Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study.

Krynitz B, Edgren G, Lindelöf B, Baecklund E, Brattström C, Wilczek H, Smedby KE.

Int J Cancer. 2013 Mar 15;132(6):1429-38. doi: 10.1002/ijc.27765. Epub 2012 Aug 28.

8.

Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit.

Collett D, Mumford L, Banner NR, Neuberger J, Watson C.

Am J Transplant. 2010 Aug;10(8):1889-96. doi: 10.1111/j.1600-6143.2010.03181.x.

9.

Risk of malignant neoplasms after liver transplantation: a population-based study.

Aberg F, Pukkala E, Höckerstedt K, Sankila R, Isoniemi H.

Liver Transpl. 2008 Oct;14(10):1428-36. doi: 10.1002/lt.21475.

10.

Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries.

Baccarani U, Piselli P, Serraino D, Adani GL, Lorenzin D, Gambato M, Buda A, Zanus G, Vitale A, De Paoli A, Cimaglia C, Bresadola V, Toniutto P, Risaliti A, Cillo U, Bresadola F, Burra P.

Dig Liver Dis. 2010 Jan;42(1):55-60. doi: 10.1016/j.dld.2009.04.017. Epub 2009 Jun 3.

PMID:
19497797
11.

Risk of hepatobiliary cancer after solid organ transplant in the United States.

Koshiol J, Pawlish K, Goodman MT, McGlynn KA, Engels EA.

Clin Gastroenterol Hepatol. 2014 Sep;12(9):1541-9.e3. doi: 10.1016/j.cgh.2013.12.018. Epub 2013 Dec 19.

12.

Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection.

Schrem H, Kurok M, Kaltenborn A, Vogel A, Walter U, Zachau L, Manns MP, Klempnauer J, Kleine M.

Liver Transpl. 2013 Nov;19(11):1252-61. doi: 10.1002/lt.23722. Epub 2013 Sep 14.

13.

Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency?

Vajdic CM, Mao L, van Leeuwen MT, Kirkpatrick P, Grulich AE, Riminton S.

Blood. 2010 Aug 26;116(8):1228-34. doi: 10.1182/blood-2010-03-272351. Epub 2010 May 13.

14.

Racial/ethnic differences in cancer risk after kidney transplantation.

Hall EC, Segev DL, Engels EA.

Am J Transplant. 2013 Mar;13(3):714-20. doi: 10.1111/ajt.12066. Epub 2013 Jan 17.

15.

De novo malignancy post-liver transplantation: a single center, population controlled study.

Chatrath H, Berman K, Vuppalanchi R, Slaven J, Kwo P, Tector AJ, Chalasani N, Ghabril M.

Clin Transplant. 2013 Jul-Aug;27(4):582-90. doi: 10.1111/ctr.12171. Epub 2013 Jun 30.

16.

Trends in invasive disease due to Candida species following heart and lung transplantation.

Schaenman JM, Rosso F, Austin JM, Baron EJ, Gamberg P, Miller J, Oyer PE, Robbins RC, Montoya JG.

Transpl Infect Dis. 2009 Apr;11(2):112-21. doi: 10.1111/j.1399-3062.2009.00364.x.

PMID:
19254327
17.

Implantable cardioverter-defibrillators and subsequent cancer risk: a nationwide population-based cohort study.

Pedersen SB, Nielsen JC, Bøtker HE, Farkas DK, Schmidt M, Sørensen HT.

Europace. 2015 Jun;17(6):902-8. doi: 10.1093/europace/euv076. Epub 2015 Apr 2.

PMID:
25840286
18.

Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009.

Piselli P, Serraino D, Segoloni GP, Sandrini S, Piredda GB, Scolari MP, Rigotti P, Busnach G, Messa P, Donati D, Schena FP, Maresca MC, Tisone G, Veroux M, Sparacino V, Pisani F, Citterio F; Immunosuppression and Cancer Study Group.

Eur J Cancer. 2013 Jan;49(2):336-44. doi: 10.1016/j.ejca.2012.09.013. Epub 2012 Oct 10.

PMID:
23062667
19.

Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study.

Jiang Y, Villeneuve PJ, Fenton SS, Schaubel DE, Lilly L, Mao Y.

Liver Transpl. 2008 Nov;14(11):1588-97. doi: 10.1002/lt.21554.

20.

Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation.

Keck BM, Bennett LE, Fiol BS, Dally OP, Novick RJ, Hosenpud JD.

Clin Transpl. 1996:31-45.

PMID:
9286557
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk